164 related articles for article (PubMed ID: 27539099)
21. Clinical usefulness of the thickness of preperitoneal and subcutaneous fat layer in the abdomen estimated by ultrasonography for diagnosing abdominal obesity in each type of impaired glucose tolerance in man.
Soyama A; Nishikawa T; Ishizuka T; Ito H; Saito J; Yagi K; Saito Y
Endocr J; 2005 Apr; 52(2):229-36. PubMed ID: 15863953
[TBL] [Abstract][Full Text] [Related]
22. Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice.
Dong J; Xu H; Xu H; Wang PF; Cai GJ; Song HF; Wang CC; Dong ZT; Ju YJ; Jiang ZY
PLoS One; 2013; 8(12):e83397. PubMed ID: 24391760
[TBL] [Abstract][Full Text] [Related]
23. Low level of Nesfatin-1 is associated with gestational diabetes mellitus.
Kucukler FK; Gorkem U; Simsek Y; Kocabas R; Gulen S; Guler S
Gynecol Endocrinol; 2016 Sep; 32(9):759-761. PubMed ID: 27153231
[TBL] [Abstract][Full Text] [Related]
24. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
[TBL] [Abstract][Full Text] [Related]
25. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome.
Shen P; Han Y; Cai B; Wang Y
Sleep Breath; 2015 May; 19(2):515-22. PubMed ID: 25056666
[TBL] [Abstract][Full Text] [Related]
26. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.
Yip WCY; Sequeira IR; Plank LD; Poppitt SD
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29165385
[TBL] [Abstract][Full Text] [Related]
28. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L
Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance and beta-cell dysfunction in people with prediabetes according to criteria based on glycemia and glycosylated hemoglobin.
Tura A; Göbl C; Moro E; Pacini G
Endocr J; 2017 Jan; 64(1):117-122. PubMed ID: 27628439
[TBL] [Abstract][Full Text] [Related]
30. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
Hussein MS; Abushady MM; Refaat S; Ibrahim R
Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
[TBL] [Abstract][Full Text] [Related]
31. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c.
Zagami RM; Di Pino A; Urbano F; Piro S; Purrello F; Rabuazzo AM
Atherosclerosis; 2015 Dec; 243(2):395-401. PubMed ID: 26520892
[TBL] [Abstract][Full Text] [Related]
32. [NESFATIN-1 ACTIVITY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PREDIABETES, TYPE 2 DIABETES].
Kovalyova O; Ashcheulova T; Demydenko A; Vizir M; Kochubiei O
Georgian Med News; 2017 Feb; (263):44-49. PubMed ID: 28452726
[TBL] [Abstract][Full Text] [Related]
33. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans.
Li QC; Wang HY; Chen X; Guan HZ; Jiang ZY
Regul Pept; 2010 Jan; 159(1-3):72-7. PubMed ID: 19896982
[TBL] [Abstract][Full Text] [Related]
34. Insulin secretion and sensitivity in Bangladeshi prediabetic subjects.
Rahman MH; Hafizur RM; Nahar Q; Khan AR; Ali L
J Diabetes Complications; 2010; 24(1):37-42. PubMed ID: 19010062
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Accuracies of Glycated Hemoglobin, Fructosamine, and Homeostasis Model Assessment of Insulin Resistance in Predicting Impaired Fasting Glucose, Impaired Glucose Tolerance, or New Onset Diabetes After Transplantation.
Rosettenstein K; Viecelli A; Yong K; Nguyen HD; Chakera A; Chan D; Dogra G; Lim EM; Wong G; Lim WH
Transplantation; 2016 Jul; 100(7):1571-9. PubMed ID: 26437275
[TBL] [Abstract][Full Text] [Related]
36. Pre-diabetes in Italian obese children and youngsters.
Brufani C; Fintini D; Ciampalini P; Nocerino V; Crea F; Giannone G; Patera PI; Valerio G; Cappa M; Barbetti F
J Endocrinol Invest; 2011 Oct; 34(9):e275-80. PubMed ID: 21666412
[TBL] [Abstract][Full Text] [Related]
37. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance.
Anwar GM; Yamamah G; Ibrahim A; El-Lebedy D; Farid TM; Mahmoud R
Regul Pept; 2014 Jan; 188():21-4. PubMed ID: 24333832
[TBL] [Abstract][Full Text] [Related]
38. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.
Zhang F; Tang X; Cao H; Lü Q; Li N; Liu Y; Zhang X; Zhang Y; Cao M; Wan J; An Z; Tong N
Int J Med Sci; 2012; 9(7):574-81. PubMed ID: 22991496
[TBL] [Abstract][Full Text] [Related]
39. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
Madhu SV; Muduli SK; Avasthi R
Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
[TBL] [Abstract][Full Text] [Related]
40. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
Bergman M; Chetrit A; Roth J; Dankner R
Diabetes Metab Res Rev; 2015 May; 31(4):368-75. PubMed ID: 25352076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
